Skip to Main Content

Paper Details

CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities.
Cell Rep
42
2022
CCND1, CCNE1, CDK, CDK4/6, CDKN2A, G1, RB, RB-deficient, RB-deficient models, RB-proficient models, RB1, cancer, cancer cell, cyclin, cyclin E, cyclin-dependent kinase, cyclins, gene, tumor
Author NameAffiliation
Rod BremnerLunenfeld Tanenbaum Research Institute
Daniel SchramekLunenfeld Tanenbaum Research Institute
Alana L WelmHuntsman Cancer Institute, University of Utah
Alana L WelmHuntsman Cancer Institute, University of Utah
  • 1 - 4

Datasets

Release 1.2